China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 30.06
-0.24 (-0.79%)
Apr 2, 2025, 2:45 PM CST
SHA:600511 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 22,703 | 25,819 | 21,594 | 21,051 | 23,789 | 37,205 | Upgrade
|
| Market Cap Growth | 19.57% | 19.57% | 2.58% | -11.51% | -36.06% | 80.69% | Upgrade
|
| Enterprise Value | 14,510 | 20,034 | 15,889 | 16,871 | 19,902 | 34,465 | Upgrade
|
| Last Close Price | 30.09 | 34.22 | 27.89 | 26.63 | 29.35 | 45.15 | Upgrade
|
| PE Ratio | 11.35 | 12.91 | 10.06 | 10.72 | 13.56 | 26.91 | Upgrade
|
| Forward PE | 10.75 | 10.71 | 8.91 | 10.01 | 12.87 | 19.84 | Upgrade
|
| PS Ratio | 0.45 | 0.51 | 0.44 | 0.46 | 0.51 | 0.92 | Upgrade
|
| PB Ratio | 1.33 | 1.36 | 1.23 | 1.33 | 1.66 | 2.84 | Upgrade
|
| P/TBV Ratio | 1.55 | 1.55 | 1.41 | 1.53 | 1.93 | 3.39 | Upgrade
|
| P/FCF Ratio | 14.85 | 16.89 | 8.37 | 9.29 | 12.77 | 30.18 | Upgrade
|
| P/OCF Ratio | 15.56 | 15.56 | 7.92 | 8.79 | 12.15 | 28.58 | Upgrade
|
| PEG Ratio | 5.37 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 | Upgrade
|
| EV/Sales Ratio | 0.29 | 0.40 | 0.32 | 0.37 | 0.43 | 0.85 | Upgrade
|
| EV/EBITDA Ratio | 6.36 | 8.88 | 6.41 | 6.96 | 9.24 | 20.65 | Upgrade
|
| EV/EBIT Ratio | 6.79 | 9.37 | 6.69 | 7.28 | 9.69 | 22.01 | Upgrade
|
| EV/FCF Ratio | 9.49 | 13.11 | 6.16 | 7.45 | 10.69 | 27.96 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.03 | 0.03 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.37 | 0.37 | 0.21 | 0.21 | 0.31 | 0.46 | Upgrade
|
| Debt / FCF Ratio | 0.55 | 0.55 | 0.21 | 0.23 | 0.38 | 0.65 | Upgrade
|
| Asset Turnover | 1.50 | 1.50 | 1.60 | 1.58 | 1.76 | 1.65 | Upgrade
|
| Inventory Turnover | 10.54 | 10.54 | 11.90 | 11.53 | 13.05 | 11.63 | Upgrade
|
| Quick Ratio | 1.70 | 1.70 | 1.73 | 1.71 | 1.63 | 1.68 | Upgrade
|
| Current Ratio | 2.04 | 2.04 | 2.04 | 2.02 | 1.93 | 1.97 | Upgrade
|
| Return on Equity (ROE) | 11.67% | 11.67% | 13.98% | 14.09% | 14.05% | 11.95% | Upgrade
|
| Return on Assets (ROA) | 3.96% | 3.96% | 4.78% | 5.03% | 4.85% | 3.99% | Upgrade
|
| Return on Capital (ROIC) | 7.05% | 7.05% | 8.61% | 9.22% | 8.87% | 7.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 10.60% | 12.80% | 13.70% | 13.50% | 11.50% | Upgrade
|
| Earnings Yield | 8.81% | 7.75% | 9.94% | 9.33% | 7.37% | 3.72% | Upgrade
|
| FCF Yield | 6.73% | 5.92% | 11.96% | 10.76% | 7.83% | 3.31% | Upgrade
|
| Dividend Yield | 2.82% | - | 3.06% | 2.94% | 2.38% | 1.22% | Upgrade
|
| Payout Ratio | 34.12% | 34.12% | 33.06% | 31.16% | 36.36% | 44.34% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | -0.00% | 0.00% | 0.00% | -0.00% | 0.98% | Upgrade
|
| Total Shareholder Return | 2.82% | -0.00% | 3.06% | 2.94% | 2.38% | 2.20% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.